Massive 5-Year psoriasis study reveals how treatments perform in real life
NCT ID NCT02786186
Summary
This study followed 2,376 adults with moderate-to-severe plaque psoriasis for 5 years to understand how different treatments work in real-world settings. Researchers compared the safety and effectiveness of the drug secukinumab against other approved therapies like biologics, pills, and light therapy. The goal was to gather practical evidence about side effects and treatment results that doctors and patients can use when making decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Edmonton, Alberta, T6G 1C3, Canada
-
Novartis Investigative Site
Nanaimo, British Columbia, V9T 1W1, Canada
-
Novartis Investigative Site
Surrey, British Columbia, V3R 6A7, Canada
-
Novartis Investigative Site
Vancouver, British Columbia, V5Z 1M9, Canada
-
Novartis Investigative Site
Brandon, Manitoba, R7A 0L5, Canada
-
Novartis Investigative Site
Winnepeg, Manitoba, R3M1Z9, Canada
-
Novartis Investigative Site
Winnipeg, Manitoba, R3C 0N2, Canada
-
Novartis Investigative Site
Fredericton, New Brunswick, E3B 1G9, Canada
-
Novartis Investigative Site
St. John's, Newfoundland and Labrador, A1A 4Y3, Canada
-
Novartis Investigative Site
St. John's, Newfoundland and Labrador, A1C 2H5, Canada
-
Novartis Investigative Site
Hamilton, Ontario, L8N 3Z5, Canada
-
Novartis Investigative Site
London, Ontario, N6A 3H7, Canada
-
Novartis Investigative Site
Nepean, Ontario, K2G 6E2, Canada
Conditions
Explore the condition pages connected to this study.